93 related articles for article (PubMed ID: 4783374)
1. [Contraceptives and erythema nodosum].
Wislicki L
Harefuah; 1973 Dec; 85(11):534-5. PubMed ID: 4783374
[No Abstract] [Full Text] [Related]
2. Erythema nodosum secondary to the use of oral contraceptive. A case report.
Stumbo WG
J Ky Med Assoc; 1973 Jul; 71(7):433-4. PubMed ID: 4725131
[No Abstract] [Full Text] [Related]
3. Erythema nodosum and contraceptive medication.
Matz MH
N Engl J Med; 1967 Feb; 276(6):351-2. PubMed ID: 6016296
[No Abstract] [Full Text] [Related]
4. [Oral contraceptives :misunderstood etiology of erythema nodosum (author's transl)].
Beaucaire G; Mouton Y; Brion M; M'Belepe R; Fourrier A
Sem Hop; 1980 Sep 18-25; 56(33-36):1426-8. PubMed ID: 6252635
[TBL] [Abstract][Full Text] [Related]
5. Erythema nodosum secondary to oral contraceptive usage. A case report.
Bernstein MZ; Spike JZ
J Am Podiatry Assoc; 1976 Jun; 66(6):417-8. PubMed ID: 1270752
[No Abstract] [Full Text] [Related]
6. Erythema nodosum from oral contraceptives.
Baden HP; Holcomb FD
Arch Dermatol; 1968 Dec; 98(6):634-5. PubMed ID: 5697233
[No Abstract] [Full Text] [Related]
7. Oral contraceptives and erythema nodosum.
Kirby JF; Kraft GH
Obstet Gynecol; 1972 Sep; 40(3):409-10. PubMed ID: 5054972
[No Abstract] [Full Text] [Related]
8. [Erythema nodosum and oral contraception. Demonstration of an anti-ethinyl estradiol antibody].
Touboul JL; Beaumont V; Meyniel D; Pieron R
Nouv Presse Med; 1981 Feb; 10(9):712. PubMed ID: 7208317
[TBL] [Abstract][Full Text] [Related]
9. Erythema nodosum and oral contraception.
Kariher DH
Obstet Gynecol; 1973 Aug; 42(2):323-4. PubMed ID: 4721424
[No Abstract] [Full Text] [Related]
10. [Erythema nodosum due to ovulation inhibitors?].
Riederer J
Dtsch Med Wochenschr; 1971 Dec; 96(51):1989. PubMed ID: 5131780
[No Abstract] [Full Text] [Related]
11. [Erythema nodosum caused by ovulation inhibitors?].
Milbradt R
Dtsch Med Wochenschr; 1971 Nov; 96(46):1813-4. PubMed ID: 5115875
[No Abstract] [Full Text] [Related]
12. Deaths among users of oral and nonoral contraceptives.
Fuertes-de la Haba A; Cuevas JO; Pelegrina I; Bangdiwala I
Obstet Gynecol; 1970 Oct; 36(4):597-602. PubMed ID: 5506465
[No Abstract] [Full Text] [Related]
13. Cutaneous eruptions and in vitro lymphocyte hypersensitivity. Associated with oral contraceptives and mestranol.
Savel H; Madison JF; Meeker CI
Arch Dermatol; 1970 Feb; 101(2):187-90. PubMed ID: 5413254
[No Abstract] [Full Text] [Related]
14. [Advantages and disadvantages of hormonal pregnancy regulation (so-called ovulation inhibitors)].
Hauser GA
Ther Umsch; 1968 Jun; 25(6):332-7. PubMed ID: 5733262
[No Abstract] [Full Text] [Related]
15. [Modern contraception and its hazards].
Mall-Haefeli M
Vasa; 1973; 2(2):172-5. PubMed ID: 4702345
[No Abstract] [Full Text] [Related]
16. The pill and the extremities.
Genovese VH
J Am Podiatry Assoc; 1973 Aug; 63(8):390-1. PubMed ID: 4717109
[No Abstract] [Full Text] [Related]
17. [Psychic and somatic accidents due to the pill].
Baruk H
Ann Med Psychol (Paris); 1975 Apr; 1(4):485-6. PubMed ID: 1233890
[No Abstract] [Full Text] [Related]
18. [Dermatological complications caused by oral contraceptives].
Deharo C; Berbis P; Privat Y
Fertil Contracept Sex; 1988 Apr; 16(4):299-304. PubMed ID: 12342376
[TBL] [Abstract][Full Text] [Related]
19. [Prolonged treatment with imunnosuppressives].
Dtsch Med Wochenschr; 1970 Jan; 95(1):40. PubMed ID: 5410756
[No Abstract] [Full Text] [Related]
20. [Study of family planning. V. Contraceptive methods in women].
Castelazo-Ayala L; Zárate-Treviño A
Gac Med Mex; 1968 Sep; 98(9):1138-47. PubMed ID: 5719858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
